Numbrino, which is the first branded drug in the 78-year-old company’s history, will be marketed to physicians as a local anesthetic for the mucus membranes. It will not be available in retail pharmacies. Numbrino, pronounced “numb-rhino” (rhino means “nose”), will be used for diagnostic procedures or for minor surgery on the nasal cavities of adults.